Ovarian Cancer Clinical Trials

Showing 961-980 of 1,019 trials

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

NCT00165152

To evaluate two different ways of providing information about genetic testing for BRCA1 and BRCA2 alterations. The two forms of counseling are genetic counseling and enhanced informed consent which cover similar material but are organized differently.

Breast CancerOvarian Cancer

Dana-Farber Cancer Institute150 participantsStarted Jul 1998

Boston, Massachusetts, United States • Boston, Massachusetts, United States

TERMINATEDPhase 2

ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

NCT00929162

The purpose of this study is to compare progression-free survival in patients with advanced ovarian cancer treated with ZD4054 in combination with carboplatin+paclitaxel versus placebo in combination with carboplatin+paclitaxel.

Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy

AstraZeneca120 participantsStarted Jun 2009

Berlin, Germany • Dresden, Germany • Düsseldorf, Germany +17 more locations

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

Related Searches

PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

ICON8: Weekly Chemotherapy in Ovarian Cancer

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Determine MTD, Evaluate Efficacy and Safety of Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer

Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Cost Utility Analysis in Recurrent Ovarian Cancer

A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Epidemiology of Ovarian Cancer in Taiwan

Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors